Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects.

RMD Open
Josef S SmolenMinjun Jang

Abstract

Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the progression of the disease. Optimal use of advanced imaging techniques or biomarkers may facilitate early diagnosis of RA. Even though many disease-modifying anti-rheumatic drugs (DMARDs) are available for RA treatment, biological DMARDs (bDMARDs) offer expanding therapeutic options and good outcomes in patients with RA who do not have a sufficient response to conventional synthetic DMARDs. However, high costs of bDMARDs have limited patient access to optimised disease management and increased the cost burden for healthcare systems. The advent of biosimilars led to significant cost savings driven by price competition among the reference products, which could be beneficial for healthcare systems. Healthcare provider (HCP)-patient communication and informed shared decision-making are crucial to prevent the occurrence of a nocebo effect, which results from negative perceptions that patients may have and could lead to less effective outcomes. Research has demonstrated that effective communication between HCPs and patients utilising positive framing can improve acceptance by patients to be initiated on or switched to a biosimilar and ca...Continue Reading

References

Nov 4, 1995·Lancet·F BenedettiG Maggi
May 14, 2004·Annals of the Rheumatic Diseases·F C Breedveld, J R Kalden
Oct 19, 2004·Lancet Neurology·Luana CollocaFabrizio Benedetti
Oct 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Floris van GaalenRené E M Toes
Mar 11, 2010·Annals of the Rheumatic Diseases·Josef S SmolenUNKNOWN T2T Expert Committee
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jing ShiLeendert A Trouw
Jul 17, 2012·Annals of the Rheumatic Diseases·Elisa GremeseGianfranco Ferraccioli
Mar 23, 2013·Annals of the Rheumatic Diseases·Alexandra N ColebatchPhilip G Conaghan
Apr 16, 2013·PloS One·Michael CentolaJeffrey R Curtis
Nov 29, 2013·Annals of the Rheumatic Diseases·M NeoviusUNKNOWN ARTIS Study Group
Feb 26, 2014·Nature Reviews. Rheumatology·Elisa CarlinoFabrizio Benedetti
May 15, 2015·Annals of the Rheumatic Diseases·Josef S SmolenDesirée van der Heijde
Nov 8, 2015·Arthritis & Rheumatology·Jasvinder A SinghTimothy McAlindon
Mar 11, 2016·Annals of the Rheumatic Diseases·Thomas DörnerGerd R Burmester
Apr 24, 2016·Lancet Neurology·Fabrizio BenedettiAlessandro Piedimonte
Oct 30, 2016·Lancet·Josef S SmolenIain B McInnes
Aug 18, 2016·BMJ : British Medical Journal·Espen A HaavardsholmTore K Kvien
Dec 17, 2016·Annals of the Rheumatic Diseases·Bernard CombeRonald van Vollenhoven
Aug 5, 2017·Annals of the Rheumatic Diseases·Roberto Caporali, Josef S Smolen
Sep 4, 2017·Annals of the Rheumatic Diseases·Jonathan KayUNKNOWN Task Force on the Use of Biosimilars to Treat Rheumatological Diseases
Nov 21, 2017·Joint, Bone, Spine : Revue Du Rhumatisme·Marc ScherlingerUNKNOWN FHU ACRONIM
Aug 11, 2018·Seminars in Arthritis and Rheumatism·Marc ScherlingerThierry Schaeverbeke
Oct 26, 2018·Annals of the Rheumatic Diseases·Vincent GermainUNKNOWN Fédération Hospitalo-universitaire ACRONIM
Oct 27, 2018·Nature Reviews. Rheumatology·Evrydiki KravvaritiPetros P Sfikakis
Jun 28, 2019·RMD Open·Josef S SmolenJake Yongkwon Lee
Jun 30, 2019·Drug Discovery Today·Hans C Ebbers, Huub Schellekens

❮ Previous
Next ❯

Software Mentioned

MBDA
SPAN
PERFUSE
EULAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.